Amprius Technologies’ (AMPX) Buy Rating Reiterated at HC Wainwright

Amprius Technologies (NYSE:AMPX)‘s stock had its “buy” rating restated by HC Wainwright in a report released on Tuesday, MarketBeat reports. They currently have a $18.00 price target on the stock. HC Wainwright’s price target points to a potential upside of 88.90% from the company’s current price.

Several other equities research analysts have also issued reports on AMPX. Zacks Research upgraded Amprius Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a report on Friday, July 17th. JonesTrading assumed coverage on Amprius Technologies in a report on Friday, July 10th. They set a “buy” rating and a $30.00 price target for the company. Finally, Clear Str assumed coverage on Amprius Technologies in a report on Tuesday, June 2nd. They set a “strong-buy” rating and a $33.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Amprius Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $22.09.

Amprius Technologies Trading Down 0.7%

NYSE:AMPX traded down $0.07 on Tuesday, hitting $9.53. 6,755,300 shares of the company’s stock traded hands, compared to its average volume of 7,769,974. Amprius Technologies has a 1 year low of $7.71 and a 1 year high of $24.23. The firm has a 50-day moving average price of $10.16 and a 200-day moving average price of $14.42. The company has a market cap of $1.35 billion, a PE ratio of -32.86 and a beta of 2.33.

Insider Buying and Selling

In related news, CEO Thomas M. Stepien sold 8,000 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $10.03, for a total value of $80,240.00. Following the completion of the sale, the chief executive officer directly owned 594,096 shares in the company, valued at approximately $5,958,782.88. The trade was a 1.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kang Sun sold 62,101 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $10.34, for a total value of $642,124.34. Following the completion of the sale, the director owned 1,218,397 shares of the company’s stock, valued at approximately $12,598,224.98. This trade represents a 4.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 123,311 shares of company stock worth $1,272,556. 5.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Amprius Technologies

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sei Investments Co. lifted its holdings in Amprius Technologies by 34.1% in the 1st quarter. Sei Investments Co. now owns 579,161 shares of the company’s stock worth $9,765,000 after purchasing an additional 147,375 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Amprius Technologies by 700.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 431,398 shares of the company’s stock worth $6,695,000 after buying an additional 377,485 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of Amprius Technologies by 65.7% during the first quarter. SG Americas Securities LLC now owns 423,037 shares of the company’s stock worth $7,132,000 after buying an additional 167,785 shares during the last quarter. First Trust Advisors LP lifted its holdings in shares of Amprius Technologies by 1,105.0% during the first quarter. First Trust Advisors LP now owns 394,569 shares of the company’s stock worth $6,652,000 after buying an additional 361,825 shares during the last quarter. Finally, Calamos Advisors LLC lifted its holdings in shares of Amprius Technologies by 206.2% during the first quarter. Calamos Advisors LLC now owns 364,506 shares of the company’s stock worth $6,146,000 after buying an additional 245,473 shares during the last quarter. 5.04% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Amprius secured a grant of up to $75 million from the U.S. Department of War’s Industrial Base Analysis and Sustainment program. The funding will help retrofit an existing domestic EV-battery production line to manufacture high-energy-density cells for Group 1–3 unmanned aerial systems. The award strengthens Amprius’ position as a potential U.S. defense supplier while reducing the amount of capital it must provide for capacity expansion. U.S. Awards Amprius Up to $75 Million to Expand Domestic Drone Battery Production
• Positive Sentiment: The announcement follows a strong market reaction, with shares rising sharply in the prior session. The contract addresses several longstanding concerns—including manufacturing scale, domestic supply-chain exposure and government demand—and could support revenue growth in the expanding military-drone market. The facility is ultimately intended to reach annual production of approximately 12 million cells. Amprius Secures $75 Million Grant for American High-Energy Density Battery Production
• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and maintained an $18 price target, implying substantial upside from recent trading levels. The rating reinforces the view that government-backed capacity expansion could accelerate Amprius’ path toward profitability. H.C. Wainwright Reiterates Buy Rating on Amprius Technologies
• Neutral Sentiment: The grant appears to be reimbursement-based and tied to milestones such as facility retrofitting, partner contributions, NDAA compliance, startup and production ramp-up. Therefore, the full $75 million may not be immediately available.
• Negative Sentiment: The primary risk is execution. Amprius will rely on a South Korean manufacturing partner and will not own the new facility, leaving the company exposed to conversion delays, certification issues, production problems and slower-than-expected customer adoption. Investors are likely to focus on these milestones and the upcoming third-quarter earnings report.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) develops and manufactures high-performance lithium-ion batteries designed to deliver greater energy density and power than conventional lithium-ion batteries. Its technology uses silicon nanowire anodes in place of traditional graphite anodes, enabling batteries with increased energy storage potential while supporting demanding weight and performance requirements.

The company’s battery products are designed for applications including electric aviation, unmanned aerial systems, aerospace, defense, electric mobility and other specialized markets.